Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving HIV Prevention Outcomes: Insights on Long-Acting Injectable (LAI) HIV Pre-Exposure Prophylaxis (PrEP) Patient-Reported Medication Preferences, Adherence, and Clinical Outcomes (IMPACT) in a Southern US State

NCT07379658 is registered in ClinicalTrials.gov with Anupama Raghuram MD as lead sponsor.

NCT NCT07379658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07379658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving HIV Prevention Outcomes: Insights on Long-Acting Injectable (LAI) HIV Pre-Exposure Prophylaxis (PrEP) Patient-Reported Medication Preferences, Adherence, and Clinical Outcomes (IMPACT) in a Southern US State
Lead sponsor
Anupama Raghuram MD
Phase
Observational
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
January 31, 2028
Enrollment
128 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hiv pre-exposure prophylaxis